RTG 200 (Potiga 200 mg)
Generic Name: ezogabine
Pill imprint RTG 200 has been identified as Potiga 200 mg.
Potiga is used in the treatment of seizures; epilepsy and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 200 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Potiga
- Generic Name:
- ezogabine
- Imprint:
- RTG 200
- Strength:
- 200 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Neuronal potassium channel openers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0812
- Inactive Ingredients:
- croscarmellose sodium
hypromelloses
ferric oxide yellow
soya lecithin
magnesium stearate
microcrystalline cellulose
polyvinyl alcohol
magnesium silicate
titanium dioxide
xanthan gum
More about Potiga (ezogabine)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
